Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03428243 · ClinicalTrials.gov registry record
Long-term Follow-up Study of the truSculpt Radiofrequency Device for Circumferential Reduction
A clinical trial, sponsored by Cutera.
- Completed
- Registry status
- 14
- Enrollment target
NCT03428243: Completed study, sponsored by Cutera.
NCT03428243 is a clinical trial that has completed, run by Cutera. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03428243 has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
A long-term follow-up study to evaluate the safety and efficacy of the Cutera truSculpt radiofrequency device for circumferential reduction.
Primary Outcome
Comparison of Abdominal region Measurement in cm 18 months post-treatment with C-16 TS11 Baseline.
Interventions
- DEVICE truSculpt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2017-07-12 |
| Est. Completion | 2017-12-01 |
What the finished NCT03428243 record still lists
NCT03428243 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which truSculpt is the first listed.
NCT03428243 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03428243 about?
NCT03428243 is a clinical study titled "Long-term Follow-up Study of the truSculpt Radiofrequency Device for Circumferential Reduction". A long-term follow-up study to evaluate the safety and efficacy of the Cutera truSculpt radiofrequency device for circumferential reduction.
What is the current status of trial NCT03428243?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2017-07-12. Estimated completion is 2017-12-01.
What interventions are being tested in trial NCT03428243?
The interventions under investigation include: truSculpt (DEVICE).
Who is sponsoring clinical trial NCT03428243?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy